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Multiple chemical sensitivity (MCS) or
environmental illness has been the subject
of numerous conferences (1,2), several
research papers (3), and much controversy.
What is the purpose ofyet another work-
shop on this topic? Patients report that
low-level chemical exposures are making
them ill, yet these reports ofillness are not
well supported by the knowledge bases of
toxicology or medicine. IfMCS is not clas-
sical toxicity, perhaps the next logical
assumption is that this illness has more to
do with the individual susceptibility than
with chemical toxicity. But what are the
mechanisms for this clinical phenomenon
and how can we begin to test objectively
the interaction of susceptibility factors,
chemical exposures, and illness? This was
the purpose ofour workshop.
Unlike previous conferences, this
conference was conducted as aworkshop in
which experienced MCS clinicians who
could document patient characteristics
worked with experimental investigators
from scientific disciplines related to MCS
to develop experimental approaches. This
supplement is a compilation of papers
given by invited speakers, both clinical and
methodologic, along with assigned com-
mentaries in response to some of the
papers. These papers reflect the back-
ground and the diversity of opinion that
exists in this area ofinquiry.
The paper by Fiedler and Kipen (3) is
an overview ofpublished studies that have
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characterized patients with chemical sensi-
tivity and highlights differences in case
definition and subject selection criteria
between studies. We summarize the peer-
reviewed literature on the psychiatric, neu-
ropsychologic, immunologic, and olfactory
function of patients reported to have
chemical sensitivity, and offers suggestions
for subject selection and experimental
approaches based upon the limited pub-
lished experience with individuals who
have this syndrome.
The series of clinical papers offers a
summary of patient characteristics from
both the research that has directly evaluated
patients with chemical sensitivities and
from clinical experience. The purpose of
these talks and papers was to provide back-
ground to those researchers with limited
previous access or knowledge ofMCS.
Ross (4), and Ziem and McTamney (5)
describe case studies of patients who are
unable to tolerate low-level chemical expo-
sures. Ziem and McTamney (5) further
describe the use ofvarious clinical tests for
diagnosing chemical sensitivity. The
patients discussed by these authors are good
examples ofthe heterogeneity in exposure
history and illness presentation among
patients to whom the term chemically sen-
sitive is applied. The tests and theories
described, although different from those
noted by Kipen and Fiedler (3), represent
the breadth ofclinical approaches and labo-
ratory analyses used to characterize these
patients, and challenge experimentalists
looking for a homogeneous subject pool
characterized bystandardized methodology.
Kehrl (6) comments on the clinical
surveys and emphasizes the inherent diffi-
culties in using inadequately standardized
laboratory assays or assays that are not vali-
dated for the conditions they are used
to assess.
The next group of papers discusses
divergent models to account for chemical
sensitivity. Each model has a different
experimental approach, and it is the use of
these models that is the subject of the
working groups.
Miller's model of chemical sensitivity
proposes that MCS is explained by a loss in
the ability to tolerate chemicals, which
results after an exposure (7). Subsequently,
low-level exposures trigger symptoms. This
is an expansion and development of the
concept of adaptation proposed by Rea
(8), with less emphasis on putative meta-
bolic explanations. Miller further explains
that the only method by which these
responses to exposures can be detected is
by removing patients from all exposures for
3 to 5 days (deadaptation) and then expos-
ing them to single chemicals. This para-
digm provides substantial theoretical and
logistical challenges for the design ofexper-
iments. MacPhail (9) comments on the
model proposed by Miller, and notes that
large interindividual differences commonly
are found in animal studies, and that
we should not be surprised that some indi-
viduals are more sensitive than others:
"Variation in sensitivity has rarely been the
focus of research, because scientists have
been generally preoccupied with measures
of central tendency." He recommends an
approach that examines conditioning of
adverse effects of airborne chemicals to
provide a rigorous laboratory model for
some aspects ofMCS.
Bell et al. (10) review and present
hypotheses suggesting that chemical sensi-
tivity may be a neural sensitization phe-
nomenon exemplified by time-dependent
sensitization or limbic kindling. That is,
patients become chemically sensitive follow-
ing one toxic exposure or repeated low-level
exposures separated in time. Subsequent
responses may be triggered byvery low-level
exposures. Bell points out that sensitization
is distinct from but interactive with other
neurobiological learning and memory pro-
cesses such as conditioning and habituation,
both ofwhich are emphasized in various
other discussions in the monograph.
Sorg and Prasad (11) wonder whether
nonelectrical kindling can occur. Sorg and
Prasad examine the potential involvement
ofstress and temporal changes in the devel-
opment of MCS from the perspective of
behavioral sensitization and kindling in
rodents. One model involves cross-sensiti-
zation between stress and drugs of abuse
in looking for enhancement of response
over time.
Meggs (12), on the other hand, suggests
that chemical sensitivity results through a
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process of neurogenic inflammation. He
describes preliminary results from a study
ofnasal pathology in MCS as well as other
patients in which defects in tightjunctions,
mucosal desquamation, glandular hyperpla-
sia, lymphocytic infiltrates, and peripheral
nerve fiber proliferation have been found.
He describes how this inflammation sug-
gests a model in which a positive feedback
loop is set up between the inflammatory
response to low-level irritants and the epi-
thelial changes propagated by the inflam-
mation, and that multi-organ symptoms
can then be explained by the concept of
neurogenic switching.
Lehrer (13) discusses analogies from
the behavioral literature to propose hypo-
theses and strategies for exploring the con-
tribution ofpsychological factors to MCS.
Hypotheses are based on concepts ofindi-
vidual response stereotypy, situational
response specificity, classical conditioning
and psychophysiologic arousal in response
to odor cues as models for chemical sensitiv-
ity. These strategies are tightly connected to
the experimental psychology literature, and
suggest immediately testable approaches.
Benignus (14) provides a brief and
cautionary commentary to respect the
canon ofparsimony in generating theoreti-
cal constructs to explain MCS. He suggests
careful work to connect explanatory
hypotheses to the body ofaccessible scien-
tific literature and compares the approaches
ofRea (8) and Lehrer (13).
The final series ofpapers focus on exper-
imental methods and dependent variables
that could be employed in experimental
studies suggested by the previous models.
Weiss (15) suggests that scepticism
about MCS stems, in part, from a lack of
supporting experimental data. Because of
the apparent broad variations in sensitivity
and the need to establish reproducibility,
he strongly favors the single-subject design,
emphasizing repeat observations on indi-
vidual subjects combined with appropriate
time series statistical tests.
Wetherell (16) comments from a per-
spective of psychopharmacology research
and emphasizes good study design as the
key to meaningful results when looking at
neurobehavioral end points. Cognitive and
psychomotor tests are examined from a per-
spective ofsensitivity, reliability, and valid-
ity, and the Latin Square design is proposed
as a way to resolve design issues. Difficulties
with placebos are discussed.
Newlin (17) describes abehavior-genetic
approach modeled after research on sub-
stance abuse to explore both the epidemiol-
ogy and genetics ofMCS. Opportunities
to use twin registers and comparisons or
contrasts with addiction are examined.
Eissenberg and Griffiths (18) describe
elegant and well-developed protocols for
assessing interindividual differences in sen-
sitivity to or tolerance ofcaffeine. Although
not the most prominent or challenging
problem cited by MCS subjects, such
intolerance is frequently reported and can
be evaluated without developing new test-
ing procedures, as inhalation studies would
require. Thus, a window can be opened on
the phenomenology ofunusual sensitivity of
some individuals to doses ofagents usually
well-tolerated by the rest ofthe population.
These manuscripts provide a rich insight
into the wealth ofclinical observation and
scientific challenges offered by MCS. While
two presenters were not able to submit
papers for publication, we refer the inter-
ested reader to reviews to supplement this
volume [Bascom (19) andAder et al. (20)].
Following the plenary talks and com-
mentaries, all presenters also participated in
one of five working groups. The papers
from these working groups reflect a synthe-
sis of research questions, experimental
approaches, and methods to test hypothe-
ses generated by the proposed model of
MCS (21-25). Each group was composed
of both individuals who had experience
with MCS patients and researchers who
had developed research methods relevant
to the model under discussion.
To summarize, these papers represent a
rich source ofhypotheses. The workshop
brought together clinicians and researchers
from divergent backgrounds and although
controversies arose, their interactions pro-
duced many ideas and suggestions. We
hope they will be of use to the research
community as we endeavor to understand
chemical sensitivities.
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